SCHEMBL8124205

SCHEMBL8124205

Cn1c2ccc(O)cc2c2c3c(c4c5cc(O)ccc5n(CCC#N)c4c21)C(=O)NC3=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYLK Q15746 9/20 0.75
WEE1 P30291 9/20 0.60
CHEK1 O14757 5/20 0.60
GSK3B P49841 2/20 0.54
PRKACA P17612 2/20 0.54
PLK4 O00444 1/20 0.54
AURKA O14965 1/20 0.54
PDPK1 O15530 1/20 0.54
JAK2 O60674 1/20 0.54
ROCK2 O75116 1/20 0.54
PRKD3 O94806 1/20 0.54
PAK4 O96013 1/20 0.54
CHEK2 O96017 1/20 0.54
EGFR P00533 1/20 0.54
ERBB2 P04626 1/20 0.54
PRKCG P05129 1/20 0.54
PRKCB P05771 1/20 0.54
INSR P06213 1/20 0.54
LCK P06239 1/20 0.54
CDK1 P06493 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8112585 0.95 MYLK (0.82) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL8119683 0.95 MYLK (0.82) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL9544938 0.86 MYLK (1.00) MYLKGSK3BPRKACAPLK4AURKA
SCHEMBL8112540 0.85 MYLK (1.00) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL8115236 0.84 MYLK (1.00) MYLKGSK3BPRKACAPLK4AURKA
SCHEMBL8113144 0.83 MYLK (0.80) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL8122393 0.83 MYLK (0.84) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL5906357 0.81 MYLK (1.00) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL8112576 0.81 MYLK (1.00) MYLKWEE1CHEK1GSK3BPRKACA
SCHEMBL8121530 0.81 MYLK (0.91) MYLKWEE1CHEK1GSK3BPRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0642513-B1 INDOLOCARBAZOLE IMIDES AND THEIR USE KTB TUMORFORSCHUNGSGESELLSCHAF (DE) 2000-08-09 EP claimed
US-5883114-A TREATING CANCEROUS TUMORS, INFLAMMATORY DISEASES, AND ALLERGIES GOEDECKE AKTIENGESELLSCHAFT (DE) 1999-03-16 US claimed
EP-0642513-A1 INDOLOCARBAZOLE IMIDES AND THEIR USE GÖDECKE AKTIENGESELLSCHAFT (DE) 1995-03-15 EP claimed
WO-1993024491-A1 INDOLOCARBAZOLE IMIDES AND THEIR USE Gödecke Aktiengesellschaft (DE) 1993-12-09 WO claimed
EP-0642513-B1 INDOLOCARBAZOLE IMIDES AND THEIR USE KTB TUMORFORSCHUNGSGESELLSCHAF (DE) 2000-08-09 EP disclosed
US-5945440-A Indolocarbazole imides and the use thereof GOEDECKE AKTIENGESELLSCHAFT (DE) 1999-08-31 US disclosed
EP-0930288-A1 LIQUID CRYSTAL COMPOUNDS HAVING NEGATIVE PERMITTIVITY, LIQUID CRYSTAL COMPOSITIONS, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 1999-07-21 EP disclosed
US-5883114-A TREATING CANCEROUS TUMORS, INFLAMMATORY DISEASES, AND ALLERGIES GOEDECKE AKTIENGESELLSCHAFT (DE) 1999-03-16 US disclosed
EP-0642513-A1 INDOLOCARBAZOLE IMIDES AND THEIR USE GÖDECKE AKTIENGESELLSCHAFT (DE) 1995-03-15 EP disclosed
WO-1993024491-A1 INDOLOCARBAZOLE IMIDES AND THEIR USE Gödecke Aktiengesellschaft (DE) 1993-12-09 WO disclosed